Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$938,204
-$142,342 QoQ
Shares Held
38,962
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,363
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investors Research Corp holds $5,482,615 across 10 Drug Manufacturers - General names. PFE ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
8,779 | $1,128,101 | |
| 2 | PFE |
Pfizer Inc
This page
|
38,962 | $938,204 | |
| 3 | NVO |
Novo Nordisk A S
|
18,225 | $873,706 | |
| 4 | GSK |
GSK plc
|
14,952 | $783,783 | |
| 5 | SNY |
Sanofi
|
16,468 | $702,524 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,628 | $497,145 | |
| 7 | BIIB |
Biogen Inc.
|
1,641 | $354,554 | |
| 8 | AZN |
Astrazeneca PLC
|
642 | $121,736 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $938,204 | 38,962 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,080,546 | 38,481 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $1,017,887 | 40,879 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $1,036,475 | 40,678 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $986,010 | 40,677 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,030,729 | 40,676 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $817,734 | 30,823 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,221,412 | 42,205 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,180,895 | 42,205 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,079,613 | 38,905 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,139,249 | 39,571 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,312,570 | 39,571 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $822,255 | 22,417 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $914,613 | 22,417 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,148,647 | 22,417 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $978,342 | 22,357 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,187,906 | 22,657 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,172,952 | 22,657 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,355,315 | 22,952 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $987,423 | 22,958 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $873,855 | 22,315 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $808,363 | 22,312 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $897,685 | 24,387 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $909,682 | 24,787 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $810,535 | 24,787 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $809,046 | 24,787 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||